
Dyee Capital
Asia, Fujian, China, Xiamen'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Dyee Capital is an investment firm.
Investor Profile
Dyee Capital has backed more than 8 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 13% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series D, Seed rounds (top funding stages).
- Majority of deals are located in China.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series C (50%)
- Series D (13%)
- Seed (13%)
- Series E (13%)
- Series A (13%)
Country Focus
- China (100%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Biopharma
- Medical
- Oncology
- Medical Device
- E-commerce
- Logistics
- Supply Chain Management
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Dyee Capital frequently co-invest with?
What are some of recent deals done by Dyee Capital?
Find More Investors Like Dyee Capital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides










